Il y a 2 ans : Shari Bossuyt écope de deux ans de suspension : Aucune forme d'humanité https://www.cyclisme-dopage.com/actualite/2024-01-11-rtbf-be.htm #cyclisme #dopage #Shari #Bossuyt #Létrozole
Shari Bossuyt écope de deux ans de suspension : Aucune forme d'humanité

Deux ans de suspension. Le verdict est tombé. Il est sévère et découle d'une application pure et dure du règlement de l'Agence Française de lutte contre le dopage. La cycliste Shari Bossuyt a tout fait pour se défendre mais elle ne verra pas les Jeux de Paris et doit mettre sa carrière entre parenthèses. La faute à la présence d'une faible quantité de létrozole dans son corps en mars 2023....

Il y a 3 ans : Très ému, Toon Aerts annonce être suspendu 2 ans par l'UCI pour dopage https://www.cyclisme-dopage.com/actualite/2022-12-29-rtbf-be.htm #cyclisme #dopage #ToonAerts #Létrozole
Très ému, Toon Aerts annonce être suspendu 2 ans par l'UCI pour dopage

Le coureur belge spécialiste du cyclo-cross Toon Aerts était en conférence de presse ce jeudi. L'occasion pour l'ex-membre de l'équipe Baloise Trek Lions de livrer le verdict de la procédure initiée à son encontre par l'UCI en raison de la présence de Létrozole dans son organisme lors d'un contrôle effectué en janvier dernier. Reconnu coupable, Toon Aerts est suspendu deux ans....

💊💉 #letrozole
SmPC for Letrozole 2.5 mg film-coated tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 9. Date of first authorisation/renewal of the authorisation; 10. Date of revision of the text on 11/12/2024.
🌐 https://www.medicines.org.uk/emc/product/9957/smpc
Change log: https://www.medicines.org.uk/emc/product/9957/smpc/history
Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Cipla EU Ltd

💊💉 #letrozole
SmPC for Letrozole 2.5 mg film-coated tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 9. Date of first authorisation/renewal of the authorisation; 10. Date of revision of the text on 11/12/2024.
🌐 https://www.medicines.org.uk/emc/product/9957/smpc
Change log: https://www.medicines.org.uk/emc/product/9957/smpc/history
Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Cipla EU Ltd

💊💉 #letrozole
SmPC for Letrozole 2.5 mg film-coated tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 9. Date of first authorisation/renewal of the authorisation; 10. Date of revision of the text on 11/12/2024.
🌐 https://www.medicines.org.uk/emc/product/9957/smpc
Change log: https://www.medicines.org.uk/emc/product/9957/smpc/history
Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Cipla EU Ltd

💊💉 #letrozole
SmPC for Letrozole 2.5 mg film-coated tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 9. Date of first authorisation/renewal of the authorisation; 10. Date of revision of the text on 11/12/2024.
🌐 https://www.medicines.org.uk/emc/product/9957/smpc
Change log: https://www.medicines.org.uk/emc/product/9957/smpc/history
Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Cipla EU Ltd

💊💉 #letrozole
SmPC for Letrozole 2.5 mg film-coated tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 9. Date of first authorisation/renewal of the authorisation; 10. Date of revision of the text on 11/12/2024.
🌐 https://www.medicines.org.uk/emc/product/9957/smpc
Change log: https://www.medicines.org.uk/emc/product/9957/smpc/history
Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Cipla EU Ltd

💊💉 #letrozole
SmPC for Letrozole 2.5 mg film-coated tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 9. Date of first authorisation/renewal of the authorisation; 10. Date of revision of the text on 11/12/2024.
🌐 https://www.medicines.org.uk/emc/product/9957/smpc
Change log: https://www.medicines.org.uk/emc/product/9957/smpc/history
Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Cipla EU Ltd

💊💉 #letrozole
SmPC for Letrozole 2.5 mg film-coated tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 9. Date of first authorisation/renewal of the authorisation; 10. Date of revision of the text on 11/12/2024.
🌐 https://www.medicines.org.uk/emc/product/9957/smpc
Change log: https://www.medicines.org.uk/emc/product/9957/smpc/history
Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Cipla EU Ltd

💊💉 #letrozole
SmPC for Letrozole 2.5 mg film-coated tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 9. Date of first authorisation/renewal of the authorisation; 10. Date of revision of the text on 11/12/2024.
🌐 https://www.medicines.org.uk/emc/product/9957/smpc
Change log: https://www.medicines.org.uk/emc/product/9957/smpc/history
Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)

Letrozole 2.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Cipla EU Ltd